Drawing for PICOBIOTICS

USPTO serial 88285675

PICOBIOTICS

Reviewed by CopyMark Law Group

Reg. 6823397Status 700Registered
Filing date
Status date
Registration date
Aug 23, 2022
Examiner
STIGLITZ, SUSAN R
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PICOBIOTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark H. Tidman

Mark H. Tidman Baker & Hostetler LLP1050 Connecticut Avenue, NWWashington Square, Suite 1100Washington, DC 20036-5403

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; medical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; veterinary preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; antibiotic preparations; pharmaceutical preparations, namely, antiviral preparations; probiotic supplements; probiotic supplements for medical use; probiotic formulations for veterinary use, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; probiotic formulations for medical use, namely, oral formulations, formulations for delivery to a microbiome in a human or animal, and formulations for delivery to skin, hair, mouth, gut, blood or a tissue, fluid or organ of a human or animal; microbiome modulators for veterinary purposes, namely, animal feed additives for use in animals feed to assist in digestion, growth or wellbeing; microbiome modulators for medical purposes, namely, as modulators of activity of pharmaceuticals in humans and animals; guided nuclease-based biocides; CRISPR-based biocides; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteriaACTIVE—
042Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis and testing in the field of diseases and conditions associated with bacteria; industrial analysis and industrial research services; design and development of computer hardware and software; genetic microbiology and microbiome research; genetic engineering and services; design and development of hardware and software; clinical research in the field of microbes and anti-microbial medications; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibiotics; research and development of guided nuclease-based biocides; research and development of CRISPR-based biocides; research and development of CRISPR technology for the treatment of microbial diseases; medical and scientific research, namely, conducting clinical trials for others; clinical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; bacteriological research; medical and scientific research in the field of microbes and anti-microbial medications; biological research; scientific and medical screening and assaying; chemical analysis; chemical research; Medical and health services relating to DNA, genetics and genetic pathogen testing, namely, providing medical and scientific research information in the fields of pharmaceuticals and medicineACTIVE—
044Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons in the nature of diagnostic and treatment counseling regarding the treatment of medical conditions and disease; pharmaceutical advice; medical and health services relating to DNA, genetics and genetic pathogen testing, namely, genetic testing for medical purposes; genetic counselingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 23, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 23, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 7, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 7, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 18, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 29, 2022FIXDELECTRONIC RECORD REVIEW COMPLETE—
Mar 30, 2022ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Mar 15, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 15, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Mar 15, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 15, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 15, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 10, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 10, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 9, 2022ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Sep 10, 2021GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Sep 10, 2021GNSIINQUIRY TO SUSPENSION E-MAILED—
Sep 10, 2021CNSISUSPENSION INQUIRY WRITTEN—
Aug 18, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Nov 23, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 23, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Nov 23, 2020CNSLSUSPENSION LETTER WRITTEN—
Nov 10, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 10, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 26, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 27, 2020GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Apr 27, 2020GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 27, 2020CNSISUSPENSION INQUIRY WRITTEN—
Apr 22, 2020RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Oct 15, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 15, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Oct 15, 2019CNSLSUSPENSION LETTER WRITTEN—
Oct 8, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 8, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 8, 2019ALIEASSIGNED TO LIE—
Oct 2, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 16, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 16, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 16, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 15, 2019DOCKASSIGNED TO EXAMINER—
Feb 24, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 5, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance